Danaher Corporation acquired Phenomenex, a transaction completed in January 2016.
Phenomenex operates in Life Sciences, is based in Torrance, California, USA. Phenomenex develops separation-science consumables such as chromatography columns and media that help analytical chemists in industrial, clinical, government and academic laboratories address purification and separation challenges. The business joined Danaher in November 2017, complementing Danaher's SCIEX mass-spectrometry offering and broadening its analytical-chemistry portfolio.
Expanded Danaher's life sciences business.
Danaher established the life sciences business in 2005 through the acquisition of Leica Microsystems and has expanded the business through numerous subsequent acquisitions, including the acquisitions of AB Sciex and Molecular Devices in 2010, Beckman Coulter in 2011, Pall Corporation in 2015 and Phenomenex in 2016.Danaher Corporation FY16 10-K, Item 1 Business description
Advisory firms were not disclosed for this transaction.